APOE and cancer: There is increasing evidence of potential genetic (APOE, COMT, BDNF), plasma (e.g., inflammatory molecules, circulating microRNAs, exosomes, short-chain fatty acids and others), cerebrospinal fluid and neuroimaging biomarkers of CRCI in cancer patients.